Interestingly, among the CCT3 high-expressed 8 tumors, other than in malignant cells, we also found an abnormal increase of CCT3 expression in multiple immune cells of the tumor microenvironment in CHOL, COAD, NSCLC and STAD (Figure 5 and Supplementary Figure S5). This evidence concerns the gene CCT3 and non-small cell lung carcinoma.